Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Response Genetics, Inc.
Pharmaceutical Preparations CA, United States
Nasdaq: RGDX
Company Description
Response Genetics, Inc. is a life sciences company, which is engaged in the research and development of clinical diagnostic tests for cancer. It has developed technologies for the extraction of RNA from formalin-fixed and paraffin-embedded tissues which enables to reliably recover RNA suitable for a variety of applications, such as gene expression research, development of diagnostics and microarray platforms. The company's platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
Similar to: Apricus Biosciences, Inc., AstraZeneca Plc, Skystar Bio-Pharmaceutical Co.
Featured Company
Utilico Emerging Markets Ltd.
Epsom, SU, GB
Utilico Emerging Markets Ltd. (UEM) is the UK-based global emerging markets investment arm of Computershare, Ltd. (SY: CPU) in Australia.… Learn more →
Social Monitor
You may also be interested in:
Skystar Bio-Pharmaceutical…
Xi'an, SA, CN
Skystar Bio-Pharmaceutical Co. engages in the research, development, production, marketing and sale of veterinary healthcare and medical… Learn more →
AstraZeneca Plc
London, LO, GB
AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →
Apricus Biosciences, Inc.
San Diego, CA, US
Apricus Bio, a San Diego based revenue-generating pharmaceutical company, has leveraged the flexibility of its clinically-validated… Learn more →